Michiko Ono‐Kishino

Author

Michiko Ono‐Kishino

Sumitomo Dainippon Pharma (Japan)

Also Known As

M Ono-Kishino, M. Ono‐Kishino, Michiko Ono-Kishino, Michiko Ono‐Kishino

Publications

666

Citations

H-Index

Concepts

All Affiliations

Sumitomo Dainippon Pharma (Japan)Pharmacology Research Institute

About

Michiko Ono‐Kishino is an author at Sumitomo Dainippon Pharma (Japan) specializing in physiology, medicine, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	174
2	Diabetes	3	3	174
3	Health Sciences	1	1	84
4	Social Sciences	1	1	63
5	Cell Biology	1	1	27

Michiko Ono‐Kishino

Publications

530

Citations

H-Index

Page 1

	Year	Citations
Brain‐derived Neurotrophic Factor Regulates Energy Expenditure Through the Central NervousSystem in Obese Diabetic Mice Takeshi Nonomura, Atsushi Tsuchida, Michiko Ono‐Kishino, Journal of Diabetes Research	2001	125
Brain‐derived neurotrophic factor ameliorates lipid metabolism in diabetic mice Atsushi Tsuchida, Takeshi Nonomura, Tsutomu Nakagawa, Diabetes Obesity and Metabolism	2002	100
Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice Atsushi Tsuchida, Takeshi Nonomura, Michiko Ono‐Kishino, International Journal of Obesity ObesityMetabolic SyndromeEnergy HomeostasisNeurophysiologyEnergy Expenditure	2001	84
Brain‐derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice M. Yamanaka, Atsushi Tsuchida, Tsutomu Nakagawa, Diabetes Obesity and Metabolism	2006	81
Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice Mitsugu Yamanaka, Yasushi Itakura, Michiko Ono‐Kishino, Journal of Bioscience and Bioengineering Metabolic SyndromeMolecular NeuroscienceInsulin ManagementPhysiologyDiabetes	2008	63
SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic<i>db/db</i>mice Eiji Sugaru, Tsutomu Nakagawa, Michiko Ono‐Kishino, American Journal of Physiology-Renal Physiology Renal PathologyRenal InflammationPathologyGlomerular FibrosisUrinary Albumin	2005	27
Chronic administration of DSP‐7238, a novel, potent, specific and substrate‐selective DPP IV inhibitor, improves glycaemic control and <i>β</i> ‐cell damage in diabetic mice Yoshikazu Furuta, M. Horiguchi, Eiji Sugaru, Diabetes Obesity and Metabolism	2009	18
Enhanced Effect of Combined Treatment with SMP-534 (Antifibrotic Agent) and Losartan in Diabetic Nephropathy Eiji Sugaru, Tsutomu Nakagawa, Michiko Ono‐Kishino, American Journal of Nephrology	2006	16
Amelioration of Established Diabetic Nephropathy by Combined Treatment with SMP-534 (Antifibrotic Agent) and Losartan in <i>db/db</i> Mice Eiji Sugaru, Tsutomu Nakagawa, Michiko Ono‐Kishino, Nephron Experimental Nephrology	2006	16

Page 1